Tempus AI Revenue 2023-2024 | TEM

Tempus AI annual/quarterly revenue history and growth rate from 2023 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Tempus AI revenue for the quarter ending September 30, 2024 was $0.181B, a 32.98% increase year-over-year.
  • Tempus AI revenue for the twelve months ending September 30, 2024 was $0.429B, a 11.77% increase year-over-year.
  • Tempus AI annual revenue for 2023 was $0.321B, a 39.7% decline from 2022.
  • Tempus AI annual revenue for 2022 was $0.532B, a INF% increase from .
  • Tempus AI annual revenue for was $0B, a NAN% decline from .
Tempus AI Annual Revenue
(Millions of US $)
2023 $321
2022 $532
Tempus AI Quarterly Revenue
(Millions of US $)
2024-09-30 $181
2024-06-30 $166
2024-03-31 $146
2023-12-31 $-63
2023-09-30 $136
2023-06-30 $132
2023-03-31 $116
2022-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $9.036B $0.321B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $37.870B 55.80
Hims & Hers Health (HIMS) United States $8.145B 207.11
Inspire Medical Systems (INSP) United States $5.799B 180.84
IRhythm Technologies (IRTC) United States $3.407B 0.00
Privia Health (PRVA) United States $2.742B 228.50
Enovis (ENOV) United States $2.671B 17.80
Azenta (AZTA) United States $2.470B 131.83
Clover Health Investments (CLOV) United States $2.200B 0.00
Omnicell (OMCL) United States $2.084B 68.17
Schrodinger (SDGR) United States $1.827B 0.00
10x Genomics (TXG) United States $1.816B 0.00
Phreesia (PHR) United States $1.654B 0.00
Butterfly Network (BFLY) United States $0.850B 0.00
Standard BioTools (LAB) United States $0.577B 0.00
Talkspace (TALK) United States $0.524B 0.00
Fulgent Genetics (FLGT) United States $0.509B 0.00
TruBridge (TBRG) United States $0.370B 107.91
Nyxoah SA (NYXH) Belgium $0.368B 0.00
Health Catalyst (HCAT) United States $0.343B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.229B 0.00
Pulmonx (LUNG) United States $0.224B 0.00
American Well (AMWL) United States $0.165B 0.00
MDxHealth SA (MDXH) Belgium $0.090B 0.00
EUDA Health Holdings (EUDA) Singapore $0.087B 0.00
P3 Health Partners (PIII) United States $0.065B 0.00
HeartBeam (BEAT) United States $0.064B 0.00
CareCloud (CCLD) United States $0.056B 0.00
111 (YI) China $0.050B 0.00
SHL Telemedicine (SHLT) Israel $0.047B 0.00
Outset Medical (OM) United States $0.043B 0.00
Zepp Health (ZEPP) China $0.042B 0.00
Zhongchao (ZCMD) China $0.035B 0.00
Movano (MOVE) United States $0.035B 0.00
Bullfrog AI Holdings (BFRG) United States $0.020B 0.00
Streamline Health Solutions (STRM) United States $0.020B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Precipio (PRPO) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Syra Health (SYRA) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00